BCA
AMPH icon

Berman Capital Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History

Berman Capital Advisors’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$3K Buy
179
+7
+4% +$137 ﹤0.01% 1550
2021
Q2 		$3K Buy
172
+152
+760% +$2.86K ﹤0.01% 1451
2021
Q1 		$0 Buy
+20
New +$372 ﹤0.01% 1755

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Berman Capital Advisors's AMPH Position: Q3 2021 in Review

Berman Capital Advisors increased its Amphastar Pharmaceuticals (AMPH) stake by 4.1% in Q3 2021, buying an estimated $137 and bringing the position to 179 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #1550.

Berman Capital Advisors first reported a position in AMPH in Q1 2021 and has held it in 3 quarters since. 139 funds tracked by Wall St. Rank hold AMPH as of Q3 2021.

  • Berman Capital Advisors held 179 shares of Amphastar Pharmaceuticals worth $3K as of Q3 2021.
  • Berman Capital Advisors bought 7 Amphastar Pharmaceuticals shares in Q3 2021, an estimated $137.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #1550 holding.
  • Berman Capital Advisors first reported a position in Amphastar Pharmaceuticals in Q1 2021 and has held it in 3 quarters since.
  • 139 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.